Study on Medullary Breast Carcinoma and Its Genetic Features
Author Information
Author(s): Vincent-Salomon Anne, Gruel Nadège, Lucchesi Carlo, MacGrogan Gaëtan, Dendale Remi, Sigal-Zafrani Brigitte, Longy Michel, Raynal Virginie, Pierron Gaëlle, de Mascarel Isabelle, Taris Corinne, Stoppa-Lyonnet Dominique, Pierga Jean-Yves, Salmon Rémy, Sastre-Garau Xavier, Fourquet Alain, Delattre Olivier, de Cremoux Patricia, Aurias Alain
Primary Institution: Institut Curie
Hypothesis
The study aims to identify phenotypic and genetic alterations that distinguish medullary breast carcinomas from basal-like carcinomas.
Conclusion
Medullary breast carcinomas are part of the basal-like group but have distinct genomic alterations, including higher rates of certain genetic gains and losses.
Supporting Evidence
- All tumors were negative for ER, PR, and ERBB2.
- KRTs 5/6 were more frequently expressed in MBCs (94%) than in BLCs (56%).
- TP53 mutations were found in 77% of MBCs and 83% of BLCs.
- MBCs showed a higher number of genomic gains and losses compared to BLCs.
Takeaway
This study looks at a type of breast cancer called medullary breast carcinoma and finds that it shares some traits with other aggressive breast cancers but also has unique features.
Methodology
The study involved genetic analysis and immunophenotype assessment of 33 medullary breast carcinomas and 26 basal-like carcinomas.
Potential Biases
Potential bias may arise from the selection of cases and the retrospective review process.
Limitations
The study's findings may be limited by the small sample size and the retrospective nature of the analysis.
Participant Demographics
The median age of participants with medullary breast carcinoma was 53.5 years, while for basal-like carcinoma it was 60 years.
Statistical Information
P-Value
p = 0.0004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website